Human Pancreas Analysis Program (HPAP) data indicates that GSDMD gene expression is increased 2.2-fold in β-cells from individuals with T1D compared to non-diabetic individuals (Kaestner et al. 2019), suggesting a role for GSDMD in β-cell cytotoxicity in this disease. This evidence concerns the gene GSDMD and type 1 diabetes mellitus.